SCHD vs JEPI: returns, risk and drawdowns compared
Schwab U.S. Dividend Equity ETF against JPMorgan Equity Premium Income ETF, over the same 5 years (March 2021 to October 2026) with dividends reinvested.
Data updated October 2026
SCHD
Schwab U.S. Dividend Equity ETF
10,000 became
17,651
- A year on average
- +10.5%
- Annual volatility
- 15.4%
- Deepest fall
- −17.1%
- Worst month
- −8.6%
JEPI
JPMorgan Equity Premium Income ETF
10,000 became
16,743
- A year on average
- +9.5%
- Annual volatility
- 10.0%
- Deepest fall
- −13.0%
- Worst month
- −6.3%
SCHD came out ahead by 1.0 percentage points a year from March 2021 to October 2026. SCHD swung more (15.4% against 10.0% a year). The correlation of monthly returns was 0.84: they usually moved together.
Growth of 10,000: SCHD vs JEPI
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero SCHD had returned more, below zero JEPI. SCHD was ahead in 24% of the 33 three-year periods.
Annualised 3-year return of SCHD minus that of JEPI, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: SCHD −17.1%, JEPI −13.0%.
All the figures
| SCHD | JEPI | |
|---|---|---|
| Annual return (CAGR) | +10.5% | +9.5% |
| Total return | +77% | +67% |
| Annual volatility | 15.4% | 10.0% |
| Deepest fall (month-end) | −17.1% | −13.0% |
| Worst month | −8.6% | −6.3% |
| Best month | +11.2% | +7.5% |
| Positive months | 57% | 68% |
| Best year | 2024: +8.4% | 2024: +12.6% |
| Worst year | 2022: −5.5% | 2022: −3.5% |
| 1-year return | +37.2% | +8.7% |
| 5 years, a year | +8.5% | +7.4% |
| 10 years, a year | +11.5% | — |
| Trading currency | USD | USD |
First nine rows: the same 68 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half SCHD, half JEPI
| SCHD alone | JEPI alone | 50/50 | |
|---|---|---|---|
| A year on average | +10.5% | +9.5% | +10.1% |
| Annual volatility | 15.4% | 10.0% | 12.2% |
| Deepest fall (month-end) | −17.1% | −13.0% | −15.0% |
| Worst month | −8.6% | −6.3% | −7.2% |
Because the two did not always move together, the mix swung less than the average of the two (12.2% against 12.7%). Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, SCHD or JEPI?
From March 2021 to October 2026, SCHD returned +10.5% a year and JEPI +9.5% a year, with dividends reinvested. Over rolling 3-year periods SCHD did better in 24% of cases. Past returns do not predict future returns.
Which is riskier, SCHD or JEPI?
Over the same months annual volatility was 15.4% for SCHD and 10.0% for JEPI; the deepest fall from a month-end high was 17.1% and 13.0%, and the worst single month −8.6% and −6.3%.
How correlated are SCHD and JEPI?
The correlation of their monthly returns was 0.84: they usually moved together. Combining them has historically given some diversification.
What about holding both SCHD and JEPI?
Half in each, rebalanced every month, returned +10.1% a year over the same period, with 12.2% annual volatility and a deepest month-end fall of 15.0%.
More comparisons
- SCHD — Schwab U.S. Dividend Equity ETFReturns, drawdowns and risk
- JEPI — JPMorgan Equity Premium Income ETFReturns, drawdowns and risk
- SCHD vs VYM
- SCHD vs VIG
- SCHD vs DGRO
- VOO vs SCHD
- JEPI vs JEPQ
- JEPI vs QYLD
- JEPI vs DIVO
- Backtest a portfolio on past crisesRebalancing, costs and attribution
- Portfolio Visualizer alternativesWhich tool fits which job
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.